D-0485-2026 Class II Ongoing
FDA drug recall D-0485-2026 was initiated by The Harvard Drug Group LLC on Mar 24, 2026 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is ongoing.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 22, 2026
- Initiation Date
- Mar 24, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-6734-61
Reason for recall
Failed Dissolution Specifications
Distribution pattern
US Nationwide.
Code information
Lot # N02425, Exp Date: 05/31/2027.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0485-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026